SIGN UP
LOG IN
News
AZTA
53.55
-2.19%
-1.20
Weekly Report: what happened at AZTA last week (0408-0412)?
Weekly Report · 19h ago
ROBO ETF: A Diversified Investment Into The Future
ROBO Global Robotics and Automation Index ETF invests in global companies involved in automation, AI, and robotics. The ETF is mostly focused on industry leaders from the U.S., but also includes companies from other countries. ROBO has underperformed other robotic funds but offers a diversified approach with a focus on small-cap stocks.
Seeking Alpha · 1d ago
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Needham sees BSX, CNMD, RMD and Surmodics beating Street, despite medtech slow down. Needham estimates medtech sales grew less than expected in Q1, but that Boston Scientific, CONMED and ResMed should still beat the Street. The investment firm says medtech market only grew by 5.3% in the first quarter of 2024.
Seeking Alpha · 1d ago
Azenta (AZTA) Shares Cross Below 200 DMA
NASDAQ · 5d ago
Azenta Is Maintained at Buy by Needham
Dow Jones · 04/08 23:46
Optimistic Financial Future and Strategic Growth: A Buy Rating for Azenta
TipRanks · 04/08 20:05
Weekly Report: what happened at AZTA last week (0401-0405)?
Weekly Report · 04/08 09:30
Shareholders Should Be Pleased With Azenta, Inc.'s (NASDAQ:AZTA) Price
Azenta, Inc. (NASDAQ:AZTA) has a high price-to-sales ratio of 5.1x compared to the Life Sciences industry. Almost half of the companies in the United States have a P/S ratio below 3.9x. The company's revenue growth is expected to outshine the industry in the coming years. Azenta's high revenue growth may be justified on the strength of its forecasted revenue growth.
Simply Wall St · 04/05 10:06
Azenta Price Target Cut to $60.00/Share From $64.00 by Evercore ISI Group
Dow Jones · 04/04 16:37
Azenta Is Maintained at In-Line by Evercore ISI Group
Dow Jones · 04/04 16:37
Evercore ISI Group Maintains In-Line on Azenta, Lowers Price Target to $60
Benzinga · 04/04 16:27
Analysts Conflicted on These Healthcare Names: Icon (ICLR), Schrodinger (SDGR) and Azenta (AZTA)
Analysts maintain Buy ratings on Icon, Schrodinger and Azenta. Jefferies analyst David Windley maintained a Buy rating on Icon yesterday and set a price target of $385.00. The Healthcare sector has received a lot of coverage today as analysts weigh in on companies in the sector.
TipRanks · 04/04 12:20
AZENTA INC <AZTA.O>: EVERCORE ISI CUTS TARGET PRICE TO $60 FROM $64
Reuters · 04/04 11:33
Azenta Price Target Announced at $64.00/Share by Jefferies
Dow Jones · 04/04 11:23
Azenta Initiated at Hold by Jefferies
Dow Jones · 04/04 11:23
Jefferies Initiates Coverage On Azenta with Hold Rating, Announces Price Target of $64
Benzinga · 04/04 11:13
Weekly Report: what happened at AZTA last week (0325-0329)?
Weekly Report · 04/01 09:29
Decoding 7 Analyst Evaluations For Azenta
Azenta Inc is a provider of life sciences solutions. The company has an average price target of $75.0. Azenta's revenue growth lags behind its industry peers. The firm has a high estimate of $79.00 for 12-month price targets. 7 analysts have shared their evaluations of Azenta in the last three months.
Benzinga · 03/28 13:00
Buy Rating Affirmed for Azenta: A Promising Future Backed by Strategic Growth Plans
TipRanks · 03/28 09:35
Azenta Price Target Maintained With a $75.00/Share by Needham
Dow Jones · 03/28 09:33
More
Webull provides a variety of real-time AZTA stock news. You can receive the latest news about Azenta Inc through multiple platforms. This information may help you make smarter investment decisions.
About AZTA
Azenta, Inc. is a provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company’s segments include Sample Management Solutions, Multiomics and B Medical Systems. The Sample Management Solutions segment offers end-to-end sample management products and services, including sample and repository services and core products (automated stores, cryogenic systems, automated sample tube, and consumables and instruments). The Multiomics segment provides genomic and other sample analysis services, including gene sequencing and gene synthesis. B Medical Systems segment is focused on the manufacturing and distribution of temperature-controlled storage and transportation solutions in international markets to governments, health institutions, and non-government organizations. It provides products and services through its brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey, and B Medical Systems.